Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 213170
Company: LA JOLLA PHARMA
Company: LA JOLLA PHARMA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ARTESUNATE | ARTESUNATE | UNKNOWN | INJECTABLE;INJECTION | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 05/29/2020 | ORIG-1 | Tentative Approval | Type 1 - New Molecular Entity | PRIORITY; Orphan |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/213170Orig1s000TAltr.pdf |